Drugs / QueaseEASE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02663154 | Jul 2014 → May 2015 | — | Stuart Wright | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QueaseEase | “Inhalation of commercial essential oil preparation (QueaseEASE) delivered in the commercial inhaler package in postanesthetic care unit after surgery in paediatric patients...” NCT02663154 ↗1“Children with nausea were randomized to saline placebo group or aromatherapy QueaseEase™ (Soothing Scents, Inc, Enterprise, AL: blend of ginger, lavender, mint and spearmint).” PMID 27829428 ↗ Nov 2016 |
| Known as | QueaseEASE (Soothing Scents, Inc, Enterprise, AL) | “QueaseEASE (Soothing Scents, Inc, Enterprise, AL)” NCT02663154 ↗ |
| Route | Inhaled | “Inhalation of commercial essential oil preparation (QueaseEASE)” NCT02663154 ↗ |